Gemin X Announces Positive Results in Small Cell Lung Cancer from Phase 1b Trial of Obatoclax at Annual Meeting of the American Society of Clinical Oncology
May 30, 2009
Debi wrote an interesting post today on
Here’s a quick excerpt
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today presented positive results from a Phase 1b clinical trial of its lead product candidate obatoclax (GX15-070) for the treatment of first line patients with extensive-stage small cell lung cancer (SCLC).
Read the rest of this great post here
Posted in 
